However, individual needs vary based on factors like age, stress levels, environmental exposure, and overall health status
Amplifying Physiological Responses Upon activation, GLP-1 receptors initiate a cascade of physiological responses aimed at regulating glucose metabolism and appetite
Common digestive side effects include: Nausea (affecting up to 44% of patients in clinical trials) Diarrhoea (approximately 30% of patients) Constipation (around 24% of patients) Vomiting (reported by roughly 24% of patients) Abdominal pain, bloating, and dyspepsia Gastro-oesophageal reflux symptoms These effects are typically most pronounced during dose escalation and often improve as the body adapts to the medication
GLP-1 medications may help influence appetite, fullness and calorie intake
If finalized, the rule would eliminate the legal pathway for large-scale production of compounded semaglutide, tirzepatide, and liraglutide